vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and FGI Industries Ltd. (FGI). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $30.5M, roughly 1.5× FGI Industries Ltd.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -19.9%, a 11.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -0.5%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
ABCL vs FGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $30.5M |
| Net Profit | $-8.9M | $-2.6M |
| Gross Margin | — | 26.7% |
| Operating Margin | -63.7% | -2.2% |
| Net Margin | -19.9% | -8.6% |
| Revenue YoY | 788.4% | -14.4% |
| Net Profit YoY | 73.9% | -553.1% |
| EPS (diluted) | $-0.03 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $30.5M | ||
| Q3 25 | $9.0M | $35.8M | ||
| Q2 25 | $17.1M | $31.0M | ||
| Q1 25 | $4.2M | $33.2M | ||
| Q4 24 | $5.0M | $35.6M | ||
| Q3 24 | $6.5M | $36.1M | ||
| Q2 24 | $7.3M | $29.4M | ||
| Q1 24 | $10.0M | $30.8M |
| Q4 25 | $-8.9M | $-2.6M | ||
| Q3 25 | $-57.1M | $-1.7M | ||
| Q2 25 | $-34.7M | $-1.2M | ||
| Q1 25 | $-45.6M | $-629.1K | ||
| Q4 24 | — | $-402.3K | ||
| Q3 24 | $-51.1M | $-550.1K | ||
| Q2 24 | $-36.9M | $163.6K | ||
| Q1 24 | $-40.6M | $-412.2K |
| Q4 25 | — | 26.7% | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | 28.1% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 27.4% |
| Q4 25 | -63.7% | -2.2% | ||
| Q3 25 | -851.8% | 1.0% | ||
| Q2 25 | -290.2% | -2.7% | ||
| Q1 25 | -1479.6% | -3.9% | ||
| Q4 24 | — | -3.5% | ||
| Q3 24 | -1439.4% | -0.2% | ||
| Q2 24 | -1276.2% | -1.5% | ||
| Q1 24 | -551.5% | -1.0% |
| Q4 25 | -19.9% | -8.6% | ||
| Q3 25 | -637.8% | -4.6% | ||
| Q2 25 | -203.3% | -4.0% | ||
| Q1 25 | -1077.2% | -1.9% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | -785.4% | -1.5% | ||
| Q2 24 | -504.3% | 0.6% | ||
| Q1 24 | -408.0% | -1.3% |
| Q4 25 | $-0.03 | $-1.63 | ||
| Q3 25 | $-0.19 | $-0.86 | ||
| Q2 25 | $-0.12 | $-0.64 | ||
| Q1 25 | $-0.15 | $-0.07 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | $-0.17 | $-0.29 | ||
| Q2 24 | $-0.13 | $0.08 | ||
| Q1 24 | $-0.14 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $1.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $17.3M |
| Total Assets | $1.4B | $69.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $1.9M | ||
| Q3 25 | $83.2M | $1.9M | ||
| Q2 25 | $92.4M | $2.5M | ||
| Q1 25 | $159.3M | $1.2M | ||
| Q4 24 | $156.3M | $4.6M | ||
| Q3 24 | $126.6M | $3.0M | ||
| Q2 24 | $148.3M | $1.3M | ||
| Q1 24 | $123.6M | $3.3M |
| Q4 25 | $966.9M | $17.3M | ||
| Q3 25 | $964.0M | $19.7M | ||
| Q2 25 | $1.0B | $21.3M | ||
| Q1 25 | $1.0B | $21.8M | ||
| Q4 24 | $1.1B | $22.3M | ||
| Q3 24 | $1.1B | $23.5M | ||
| Q2 24 | $1.1B | $23.8M | ||
| Q1 24 | $1.1B | $23.9M |
| Q4 25 | $1.4B | $69.5M | ||
| Q3 25 | $1.4B | $73.0M | ||
| Q2 25 | $1.4B | $71.7M | ||
| Q1 25 | $1.3B | $68.5M | ||
| Q4 24 | $1.4B | $75.5M | ||
| Q3 24 | $1.4B | $74.7M | ||
| Q2 24 | $1.4B | $69.9M | ||
| Q1 24 | $1.5B | $68.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $2.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $2.3M |
| FCF MarginFCF / Revenue | -99.4% | 7.5% |
| Capex IntensityCapex / Revenue | 21.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-212.5K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $2.3M | ||
| Q3 25 | $-52.6M | $-1.9M | ||
| Q2 25 | $-32.4M | $7.6M | ||
| Q1 25 | $-11.6M | $-7.4M | ||
| Q4 24 | $-108.6M | $617.4K | ||
| Q3 24 | $-28.9M | $-915.0K | ||
| Q2 24 | $-30.0M | $862.1K | ||
| Q1 24 | $-41.7M | $-8.0M |
| Q4 25 | $-44.6M | $2.3M | ||
| Q3 25 | $-61.5M | $-2.1M | ||
| Q2 25 | $-45.8M | $7.4M | ||
| Q1 25 | $-22.2M | $-7.7M | ||
| Q4 24 | $-187.0M | $-214.1K | ||
| Q3 24 | $-47.4M | $-1.1M | ||
| Q2 24 | $-50.1M | $281.5K | ||
| Q1 24 | $-65.8M | $-8.6M |
| Q4 25 | -99.4% | 7.5% | ||
| Q3 25 | -687.0% | -5.9% | ||
| Q2 25 | -267.9% | 23.8% | ||
| Q1 25 | -524.0% | -23.3% | ||
| Q4 24 | -3702.8% | -0.6% | ||
| Q3 24 | -728.4% | -3.0% | ||
| Q2 24 | -683.8% | 1.0% | ||
| Q1 24 | -661.5% | -28.0% |
| Q4 25 | 21.9% | 0.2% | ||
| Q3 25 | 99.7% | 0.7% | ||
| Q2 25 | 78.2% | 0.7% | ||
| Q1 25 | 251.1% | 1.1% | ||
| Q4 24 | 1552.7% | 2.3% | ||
| Q3 24 | 284.6% | 0.5% | ||
| Q2 24 | 274.6% | 2.0% | ||
| Q1 24 | 242.5% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
